SMV
Sofinnova Management VIII Portfolio holdings
AUM
$183M
This Quarter Return
+18.41%
1 Year Return
+2.31%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$164M
AUM Growth
+$164M
(-8.1%)
Cap. Flow
-$87.2M
Cap. Flow
% of AUM
-53.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
2
Closed
2
Top Buys
| 1 |
NCNA
NuCana
NCNA
|
$12.2M |
Top Sells
| 1 |
Synlogic
SYBX
|
$48.5M |
| 2 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$27.3M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$18.9M |
| 4 |
INNL
Innocoll Holdings plc Ordinary Shares
INNL
|
$4.8M |
Sector Composition
| 1 | Healthcare | 73.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCE
1
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $42.9M | 26.16% | 481,270 -211,858 | -31% | -$18.9M |
|
2
Aclaris Therapeutics
ACRS
$209M
| $39.7M | 24.23% | 1,539,480 | – | – |
|
|
OBSV
3
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $30.5M | 18.61% | 3,749,623 | – | – |
|
4
Natera
NTRA
$23.1B
| $20M | 12.18% | 1,550,280 | – | – |
|
|
NCNA
5
NuCana
NCNA
$6.09M
| $12.2M | 7.47% | +666,666 | New | +$12.2M |
|
|
6
Synlogic
SYBX
$17M
| $8.08M | 4.93% | 424,972 -2,549,840 | -86% | -$48.5M |
|
|
CYTO
7
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $6.41M | 3.91% | 7,818,175 | – | – |
|
8
Ocugen
OCGN
$319M
| $4.11M | 2.51% | 2,077,040 | – | – |
|
|
ARAV
9
DELISTED
Aravive, Inc. Common Stock
ARAV
| – | – | -1,563,260 | Closed | -$27.3M |
|
|
INNL
10
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| – | – | -2,103,173 | Closed | -$4.8M |
|